Intrinsic Value

Aeglea BioTherapeutics, Inc. (AGLE)


-0.00 (-3.03%)

Enterprise Value -
Net Debt -30.23
Equity Value -
Shares Outstanding 84.28
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt